thymoquinone has been researched along with Lung Neoplasms in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 8 (53.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, S; Hassan, MI; Husain, M; Mohammad, T; Padder, RA | 1 |
| Anandakumar, P; Nithya, G; Sakthisekaran, D; Santhanasabapathy, R; Vanitha, MK | 1 |
| Chen, H; Cheng, J; Du, J; Fu, J; Fu, S; Guo, K; He, J; He, T; Li, D; Li, T; Liu, S; Liu, X; Liu, Z; Qian, J; Song, B; Tan, Q; Zhang, L; Zhou, B | 1 |
| Asa, SL; Azmi, AS; Bajor, D; Cjakrabarti, S; Kaseb, AO; Mahipal, A; Mohamed, A; Selfridge, JE; Tirumani, SH | 1 |
| Dang, W; Liu, L; Liu, X; Zhang, Y | 1 |
| Garnique, AMB; Machado-Santelli, GM; Rezende-Teixeira, P | 1 |
| Adhikary, A; Ahir, M; Bhattacharya, S; Chattopadhyay, S; Das, S; Ghosh, A; Ghosh, S; Gupta, P; Sarker, S; Upadhyay, P | 1 |
| Aras, Ö; Bilgin, ES; Çakar, B; Ergönül, A; Göker, E; Güldü, ÖK; İnce, İ; Medine, Eİ; Müftüler, ZB; Parlak, Y; Takan, G; Ünak, P; Yıldırım, Y | 1 |
| Ahmed, I; Al Fayi, M; Chandramoorthy, HC; Dera, AA; Rajagopalan, P | 1 |
| Azimi-Nezhad, M; Farkhondeh, T; Samarghandian, S | 1 |
| Celik, S; Gunay, E; Hazman, O; Koyuncu, T; Ozdemir, M; Ozyurek, A; Ulasli, SS; Unlu, M | 1 |
| Kuang, XR; Lv, PT; Yan, XX; Yang, J | 1 |
| Cheng, J; Fu, J; Fu, S; Khan, MA; Mei, Z; Tania, M; Wei, C; Xu, J | 1 |
| Glass, J; Jafri, SH; Kleiner-Hancock, H; Prince, M; Shi, R; Zhang, S | 1 |
| Adem, A; Al Safi, M; Al Sultan, MA; Al-Salam, S; Arafat, K; Attoub, S; Raza, H; Sperandio, O; Takahashi, T | 1 |
15 other study(ies) available for thymoquinone and Lung Neoplasms
| Article | Year |
|---|---|
Thymoquinone and quercetin induce enhanced apoptosis in non-small cell lung cancer in combination through the Bax/Bcl2 cascade.
Topics: A549 Cells; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-bcl-2; Quercetin; Signal Transduction | 2022 |
Antioxidant, antiproliferative, and apoptotic activity of thymoquinone against benzo(a)pyrene-induced experimental lung cancer.
Topics: Animals; Antioxidants; Benzo(a)pyrene; Body Weight; Carcinogenesis; Lung; Lung Neoplasms; Mice | 2023 |
Impact of
Topics: Adenosine; COVID-19; COVID-19 Drug Treatment; Humans; Lung Neoplasms; Male; Mutation; Prognosis; Prostatic Neoplasms; SARS-CoV-2; Serine Endopeptidases | 2022 |
Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination.
Topics: Carcinoma, Neuroendocrine; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Infant, Newborn; Ipilimumab; Lung Neoplasms; Neuroendocrine Tumors; Nivolumab; Quality of Life | 2022 |
Thymoquinone inhibits lung cancer stem cell properties via triggering YAP degradation.
Topics: Cell Line, Tumor; Humans; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplastic Stem Cells | 2023 |
Telomerase inhibitors TMPyP4 and thymoquinone decreased cell proliferation and induced cell death in the non-small cell lung cancer cell line LC-HK2, modifying the pattern of focal adhesion.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Focal Adhesions; Humans; Lung Neoplasms; Telomerase | 2023 |
Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Chick Embryo; Female; Humans; Lung Neoplasms; Mice, Inbred BALB C; MicroRNAs; Nanoparticles; Polyesters; Polyethylene Glycols; Reactive Oxygen Species; Transferrin; Wound Healing | 2019 |
Thymoquinone Glucuronide Conjugated Magnetic Nanoparticle for Bimodal Imaging and Treatment of Cancer as a Novel Theranostic Platform.
Topics: Animals; Benzoquinones; Cell Line, Tumor; Disease Models, Animal; Glucuronides; Iodine Radioisotopes; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Mice, Nude; Precision Medicine; Rabbits; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2021 |
Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Cycle; Cell Line; Cell Proliferation; Disease Models, Animal; Drug Combinations; Drug Screening Assays, Antitumor; Female; Humans; In Vitro Techniques; Indoles; Lung Neoplasms; Mice; Mice, Nude; Models, Biological; Neoplasms, Experimental; Oximes | 2020 |
Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells.
Topics: A549 Cells; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Caspases; Cell Line, Tumor; Cell Survival; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2019 |
Anticancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small cell lung cancer cells exposed to benzo(a)pyrene.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzo(a)pyrene; Benzoquinones; Caffeic Acids; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cytokines; Glutathione; Humans; Lung Neoplasms; Malondialdehyde; NF-kappa B; Nitric Oxide; Phenylethyl Alcohol; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tumor Cells, Cultured | 2013 |
Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathway.
Topics: Antineoplastic Agents; Benzoquinones; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness | 2015 |
Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzoquinones; Breast Neoplasms; Cell Movement; DNA Methylation; Dose-Response Relationship, Drug; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; HeLa Cells; Humans; Lung Neoplasms; Mice, Inbred BALB C; Neoplasm Invasiveness; Nuclear Proteins; Promoter Regions, Genetic; RNA Interference; RNA, Messenger; Signal Transduction; Time Factors; Transcription, Genetic; Transfection; Twist-Related Protein 1 | 2015 |
Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cisplatin; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Lipopolysaccharides; Lung Neoplasms; Maximum Tolerated Dose; Mice; Mice, SCID; Mice, Transgenic; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Small Cell Lung Carcinoma; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Movement; Cisplatin; Drug Synergism; Female; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasms; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays | 2013 |